Envista Holdings Corp (NVST)

Environment story

Envista demonstrates moderate environmental performance with acknowledged climate risks but limited transparency on emissions reduction. The company references climate-related risks and regulations as material but provides no disclosed Scope 1, 2, or 3 emissions data, net-zero target year, or renewable energy percentage in the 10-K. The 10-K mentions a Sustainability Report on the company website (not incorporated by reference), suggesting material ESG data may exist off-filing. The company acknowledges environmental laws and regulations governing air, water, waste, and workplace safety, and notes that products are subject to EPA regulation. No major environmental controversies, toxic-waste incidents, or water-related disputes are documented in the provided filings. The absence of quantified decarbonization metrics and disclosed targets results in a cautious baseline score.

Social story

Envista reports a workforce of approximately 12,000 employees (3,000 US, 9,000 international) with collective bargaining arrangements in certain European countries. The 10-K discloses a 2025 employee engagement survey with 95% participation, 73% feeling engaged, and 80% reporting effective manager leadership—indicating moderate workforce satisfaction. The company emphasizes competitive compensation, benefits, paid parental leave, and mental health support globally. No CEO-to-worker pay ratio is disclosed. No documented union-suppression activities, major strikes, or labor litigation within 24 months are reported in the filing. Diversity metrics (women, racial/ethnic representation in leadership or workforce) are not disclosed in the 10-K. The company founded the Envista Smile Project (501(c)(3)) in 2021 to support oral health access in disadvantaged communities. Supply-chain human-rights risks are not explicitly addressed in the provided excerpts. Overall, the company demonstrates engagement investments but lacks granular diversity and pay-equity disclosures.

Governance story

Envista's governance profile shows standard dental/medical-device company structures. Board composition and independence metrics are not disclosed in the 10-K excerpt provided. The company operates under a single-class common-stock structure (no dual-class voting disclosed). The Compensation Committee oversees executive and equity compensation. The Board is actively engaged in overseeing people, culture, succession planning, and enterprise risk management. No significant antitrust, SEC consent decrees, or active financial-fraud proceedings are disclosed in the provided sections. The company acknowledges extensive FDA and international medical-device regulation compliance, including Quality Management System Regulation (QMSR) effective Feb 2026, and references EU MDR, UK GDPR, and Chinese PIPL/GDPR-equivalent compliance requirements. Lobbying spend and political contributions are not quantified in the 10-K. No shareholder proposals or proxy fights are documented in the provided excerpts. The company notes it may be subject to litigation and regulatory proceedings 'incidental to business' but none are material enough to detail.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of Envista Holdings Corp. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open Envista Holdings Corp in the app for interactive charts and portfolio building.

More in Healthcare